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Abstract 
Introduction: Differentiation of fibroblasts to myofibroblasts is an initial and very important 
event in tumor genesis. Myofibroblasts produce proteinases that stimulate invasion in cancers. Due 
to the more malignant potential of oral squamous cell carcinoma (OSCC) compared to cutaneous 
squamous cell carcinoma (CSCC) , the aim of the present study was to compare myofibroblasts 
between OSCC and CSCC to understand whether myofibroblasts can help more malignant 
potential of OSCC compared to CSCC or not. 
Materials &Methods: This cross-sectional study included 40 cases of OSCC and CSCC and 20 
cases of normal skin and normal oral mucosa. Then, 4-micron sections of paraffin-embedded 
tissue blocks of studied groups were stained immunohistochemically with α-SMA antibody. Mean 
percentage of myofibroblasts was calculated in invasive fronts of OSCCs with CSCCs and also in 
normal samples and staining intensity of cells for α-SMA marker and distribution pattern of 
myofibroblasts were determined. 
Results: The differences of average percentage of myofibroblasts in OSCC and CSCC compared 
to normal groups were significant (Pvalue= 0.007 and Pvalue=0.003 respectively), but when we 
compared OSCCs and CSCCs, the difference was not significant. Also, there were no significant 
differences between OSCC and CSCC with regard to staining intensity and pattern. 
Conclusion: Different biologic behavior of OSCC compared to CSCC doesn’t depend on 
myofibroblasts and other factors can be involved. 
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اّ تسلابٍربیفَیه یًاٍارف یا ِسیاقه یبایزرا تسَپ ٍ ىاّد یشرفگٌس لَلس مٌَیسراک يیب 
 
ٍد یلعدىایجاح للها نیرک ،داژً یحلاص ُاشًاْج ،یتدایس ُدیپس ،یًا یکلیت ُداز سابع دیوح ، یتخدیب* 
 
ُدیکچ 
ِهدقه: یه ِب تسلابٍزبیف شیبوت ییبّسبٌیئتٍزپ بّ تسلابٍزبیفَیه .تسا رَهَت دبجیا رد نْه ربیسب ٍ ِیلٍا داذیٍر کی تسلابٍزبیفَ
( ىبّد یشزفگٌس لَلس مٌَیسربک زتشیب یویخذب لیسًبتپ لیلذب .ذٌٌک یه کیزحت بّ زسًبک رد ار نجبْت ِک ذٌٌکیه ذیلَتOSCC )
( تسَپ یشزفگٌس لَلس مٌَیسربک ِب تبسًCSCCیا سا فذّ ،) يیب تسلابٍزبیفَیه ِسیبقه ِعلبطه يOSCC  ٍCSCC  
 زتشیب نیخذب لیسًبتپ ِب ذًٌاَت یه تسلابٍزبیفَیه بیآ ِک نیببیرد بت تساOSCC  بب ِسیبقه ردCSCC .ًِ بی ذٌٌک کوک 
:اّ شٍر ٍ داَه  لهبش ِعلبطه يیا02  درَهOSCC ،02 درَهCSCC   ،02   ٍ تسَپ لبهزً تفبب02  لبهزً طبخه درَه ىبّد
 عطبقه  .دَش یه4  یتًآ بب یویشَتسیًََّویا شٍر ِب ِعلبطه درَه یبّ ٍُزگ يیفاربپ رد ِتفزگ رازق یتفبب یبّ کَلب سا یًٍزکیه
 یدببα-SMA  .ذًذش یشیهآ گًر يیگًبیه یوجبْت ِْبج رد بّ تسلابٍزبیفَیه ذصردOSCCs  ٍCSCCs  ًَِوً رد شیً ٍ
یذپ گًر تذش ٍ ذش ِبسبحه لبهزً یبّ زگًبشً یازب بّ لَلس یزα-SMA ذش يییعت بّ تسلابٍزبیفَیه عیسَت یَگلا ٍ. 
:اّ ِتفای  يیگًبیه فلاتخا رد تسلابٍزبیفَیه ذصردOSCC  ٍCSCC دَب راد یٌعه لبهزً یبّ ٍُزگ ِب تبسً بیتزت ِب( 
Pvalue= 0.007 ،Pvalue=0.003 به ِک یًبهس بها ،)OSCCs  ٍCSCCs فت ،نیدزک ِسیبقه ار ،يیٌچوّ .دَبً راد یٌعه تٍب
 يیب یراد یٌعه تٍبفتOSCC  ٍCSCC .تشاذً دَجٍ یزیذپ گًر یَگلا ٍ تذش ظبحل ِب 
:یریگ ِجیتً کیصَلَیب ربتفر تٍبفت  OSCC  بب ِسیبقه ردCSCC  ذًٌاَت یه یزگید لهاَع ٍ دراذً یگتسب تسلابٍزبیفَیه ِب
.ذٌشبب لیخد 
:یدیلک ىاگژاٍ  ،مٌَیسربک،یببیسرا ،تسلابٍزبیفَیه یشزفگٌس یبْلَلس 
 
Introduction 
Oral squamous cell carcinoma (OSCC) is the most 
common oral malignancy and cutaneous squamous cell 
carcinoma (CSCC) is the second most common skin 
cancer
.[1,2]
 In solid tumors such as oral squamous cell 
carcinoma, a combination of the effects of cancer cells 
and stromal cells (i.e. fibroblasts, endothelial cells and 
inflammatory cells) has been considered as being 
involved that in harmony with each other act towards 
tumor progression, angiogenesis, local invasion and 
metastasis.
[3]
 Myofibroblasts are heterogeneous and 
multifunctional cells which show different phenotypes. 
Myofibroblasts are at first described in cutaneous ulcers 
where they contract stroma, approximate epithelial 
edges to each other and thus facilitate healing of ulcer. 
Myofibroblasts regulate stromal in physiological and 
pathological statuses via direct cell-cell contacts and 
release of matrix metalloproteinases, tissue inhibitors of 
matrix metalloproteinases, components of extracellular  
matrix growth factors, cytokines, chemokines and lipid 
products and via expression of specific receptors.    
Some of normal tissues such as gastrointestinal tract and  
 
lungs have also myofibroblasts. Beside their role in 
healing of ulcers, myofibroblasts are necessary for 
tissue morphogenesis and help to stem cell niches and 
mucosal immunity.
[4]
  
Carcinoma-associated fibroblasts (CAFs) which 
consist of both fibroblasts and myofibroblasts are 
frequently observed in the stroma of human 
carcinomas.
[4]
 Differentiation of fibroblasts to 
myofibroblasts is an initial and very important event in 
tumorigenesis and mediates by cytokines and growth 
factors expressed by tumor cells. 
[5]
 In cancers, 
myofibroblasts are deficient or have other functions 
such as production of proteinases stimulating invasion. 
[4]
 Induction of myofibroblasts by OSCC induced factors 
that instead stimulate carcinomatous proliferation and 
result in neoplastic growth, have been shown.
[5]
 
Frequency of stromal myofibroblasts is correlated with 
worse prognosis in oral, breast and colorectal 
carcinomas. 
[6-10]
 On the other hand, malignant and 
metastatic potential for OSCC and CSCC is different. 
[11]
 OSCC and CSCC differ in terms of their prognosis. 
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For OSCC, 5- year survival rate varies between 35% 
and 45% and the risk of metastasis varies between 40% 
and 50% .
[12, 13]
 For head and neck CSCC, the risk of 
metastasis is 11.7% and 5-years survival is 54% .
[14, 15]
 
Therefore, the aim of the present study was to compare 
myofibroblasts between OSCC and CSCC, to 
understand whether myofibroblasts can help more 
malignant potential of OSCC compared to CSCC or not.  
 
 
Materials&Methods  
This cross-sectional study included 60 samples 
(including 20 low-grade OSCCs, 20 low-grade CSCCs, 
10 normal oral mucosa, 10 normal skins). Then, 4-
micron sections of paraffin-embedded tissue blocks of 
studied groups were stained immunohistochemically 
with α-SMA antibody (Bond™ Ready-to-Use Primary 
Antibody Smooth Muscle Actin (alpha sm-1) [ a mouse 
anti-human monoclonal antibody]; Leica Biosystems, 
Newcastle,  United Kingdom, Product Code: PA0.943 
Clone: alpha sm-1, Ig Class: IgG2a) .  Spindle stromal 
cells which indicated positive staining for alpha smooth 
muscle actin (α-SMA) and cytoplasmic staining were 
considered as myofibroblasts.
[16]
 α-SMA+ smooth 
muscle cells of blood vessels' wall were not considered 
in this calculation.
[17]
Percentage of myofibroblasts 
among stromal cells under an optical microscope at 10 
successive fields in invasive fronts of OSCCs and 
CSCCs was calculated. At 400X magnification light 
microscopic examination, percentage of α-SMA+  cells 
among stromal cells (non-inflammatory and non-smooth  
muscle of blood vessels’ wall) in sub-epithelial 
connective tissue of normal mucosa and skin was 
calculated in 10 successive microscopic fields and their 
means were recorded. In OSCCs and CSCCs, 
percentage of α-SMA+ cells among stromal cells (non-
inflammatory and non-smooth muscle of blood vessels’ 
wall) in close proximity to carcinomatous islands was 
calculated in 10 successive microscopic fields and their 
means were recorded. 
[5]
 
Percentage of α-SMA+ cells was categorized as 
following: 0=absence of positive cells; 1= 1-25% of 
cells are positive; 2=26-50% of cells are positive; 3=51-
75% of cells are positive; 4=76-100% of cells are 
positive. Intensity of cell staining for α-SMA was 
categorized as following: 0= negative; 1=weak; 2= 
moderate; 3= sever. 
[5]
 Qualitatively, presence of 
myofibroblasts was categorized as following: 
0=negative; 1=scanty; 2=abundant. Samples without 
any stromal myofibroblasts were considered as 
“negative”; samples with scattered stromal 
myofibroblasts were considered as “scanty” and 
samples with numerous and densely arranged stromal 
myofibroblasts were considered as “abundant”. [16, 18] 
Also, distribution pattern of stromal myofibroblasts in 
SCCs was categorized as “spindle” and “network” 
according to dominant pattern. 
In “spindle” pattern, at low-power and moderate-
power magnification, α-SMA+ myofibroblasts with 
spindle shape morphology attach tightly to 
carcinomatous islands or nests as one to three concentric 
layers. In “network” pattern, stromal myofibroblasts are 
very abundant and have plump shape and sometimes 
their proportion becomes greater than carcinomatous 
components; they arrange as short to moderate length 
crossover bundles and at high power magnification, 
their high density creates a multi-layered image in mind. 
[19]
 In statistical analysis, we used SPSS software and 
the normality of data was tested by Kolmogorov–
Smirnov and t-test, one way ANOWA was performed 
for qualitative data, Chi-Square test for categorical 
data.). Significance level was considered as P-value˂ 
0.05.  
Ethical Approvals: The study has been independently 
reviewed and approved by ethical board of Babol 
University of Medical Sciences. 
 
 
Results  
In this study, a total of 60 samples (20 low-grade 
OSCCs, 20 low-grade CSCCs, 10 Normal oral mucosa 
[NO] and 10 Normal skins [NS]) were investigated. We 
studied myofibroblasts in these samples with the above-
mentioned methods (Figures 1 and 2). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Myofibroblasts in invasive front of 
CSCC (40X magnification) 
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Figure 2. Myofibroblasts in invasive front of 
OSCC (400X magnification) 
 
Mean percentage of myofibroblasts: The mean 
percentage of myofibroblasts of OSCC, CSCC, NO and 
NS samples is summarized in table 1. CSCC samples 
had the highest mean percentage of myofibroblasts and 
normal oral mucosal samples had the lowest .Results 
showed that the difference of mean percentage of 
myofibroblasts between OSCC and NO (P-value = 
0.007˂0.05) and also between CSCC and NS (P-value = 
0.003˂ 0.05) was significant, but the difference of mean 
percentage of myofibroblasts between CSCC and OSCC 
was not statistically significant. (P-value = 0.97> 0.05) 
The percentage classification of myofibroblasts of 
OSCC, CSCC, NO and NS samples is summarized in 
table 2. According to table 2, the majority of OSCC and 
CSCC samples lies in second group (1-25% 
myofibroblasts); also, the majority of normal skin 
samples and half of normal oral mucosal samples has no 
myofibroblasts. Results showed that the difference of 
percentage classification of myofibroblasts between 
OSCC and NO (P-value = 0.036˂0.05) and also 
between CSCC and NS (p-value = 0.002˂ 0.05) was 
significant, but the difference of percentage 
classification of myofibroblasts between CSCC and 
OSCC was not statistically significant. (P-value = 0.16). 
Staining intensity of myofibroblasts: while the 
intensity of cell staining for α-SMA between OSCC and 
NO (P-value = 0. 001) and also between CSCC and NS 
(P-value = 0. 036˂ 0.05) was significantly different but 
the difference of intensity of cell staining for α-SMA 
between CSCC and OSCC samples was not statistically 
significant (P-value = 0.26). The majority of OSCC and 
CSCC samples had sever staining intensity for α-SMA. 
Distribution of myofibroblasts: In addition, the 
distribution pattern of stromal myofibroblasts in OSCCs 
and CSCCs had spindle pattern and was not statistically 
significant between these groups. (P-value = 0. 29)  
Qualitative classification of myofibroblasts: 
Furthermore, our results in qualitative presence of 
stromal myofibroblasts in OSCCs and CSCCs showed 
no statistically significant difference (P-value = 0. 29> 
0.05). Ultimately, the majority of OSCC and CSCC 
samples were of “scanty” group.  
 
Table 1. The mean percentage of myofibroblasts in studied groups 
Group N Mean Std.Deviation P-value 
Normal skin 10 2.2 4.1312 0.003 
cutaneous squamous cell carcinoma 20 34.2 31.1124 
oral squamous cell carcinoma 20 33.85 35.4346 0.007 
Normal oral  mucosa 10 0.9 1.5239 
 
Table 2. The classification of percentage of myofibroblasts in studied groups 
Group percentage classification of myofibroblasts P-value 
0% 1-25% 26-50% 51-75% 76-100% 
Normal skin 6 4 0 0 0  
0.002 cutaneous squamous cell carcinoma 0 10 4 3 3 
oral squamous cell carcinoma 2 10 0 5 3  
0.036 Normal oral  mucosa 5 5 0 0 0 
 
Discussion  
In this research, we found significant differences in 
mean percentage of myofibroblasts and percentage 
classification of myofibroblasts between OSCCs and  
NO, and between CSCCs and NS. Significant difference  
 
of mean percentage of myofibroblasts and percentage 
classification of myofibroblasts between OSCCs and 
NO suggest increased presence of these cells in OSCCs 
and probably their role in tissue invasion process and 
progression of OSCC. This finding is consistent with 
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other studies, which suggested that more OSCCs had 
“spindle” pattern of distribution[16, 17, 19, 20]. In their 
study, qualitatively myofibroblasts were scarce in 
normal samples just as our result. OSCCs had different 
myofibroblasts ranged from few to large numbers in 
their study which is similar to the current study. In the 
study of Seifi et al
 [17], OSCCs had “spindle” and 
“network” pattern of distribution for myofibroblasts and 
normal samples had scarce and scattered pattern; these 
findings are compatible with the results of the present 
study. In their research, more OSCCs had score 3 
(myofibroblasts constitute more than 50% of stromal 
cells), which is the same as the current finding. 
The findings of this study showed significant 
differences in mean percentage of myofibroblasts and 
percentage classification of myofibroblasts between 
CSCCs and NS suggested increased presence of these 
inflammatory cells in CSCCs and probably their role in 
tissue invasion process and progression of CSCC. This 
finding agrees with that of Kacar A et al. 
[21]
 
In compared with other researchers, Rao et al. 
[5]
 
found significant differences in myofibroblasts 
frequency between OSCCs and oral submucous fibrosis, 
but they didn’t have normal oral mucosa as control. 
They considered a role for myofibroblasts in fibrous, 
cancer progression and metastasis. In the current study, 
no significant difference was found in mean percentage 
of myofibroblasts and percentage classification of 
myofibroblasts between OSCCs and CSCCs. Although 
the malignant and metastatic potential of OSCC is more 
than CSCC, more invasive potential and poor prognosis 
of OSCC compared to CSCC are due to some factors 
except stromal myofibroblasts according to our 
findings; therefore, the role of myofibroblasts in 
different biological behavior of OSCC and CSCC is 
doubtful. Perhaps, more aggressive behavior of OSCC 
compared to CSCC is related to factors such as more 
vascularity of oral cavity compared to skin and 
subsequent easier access to lymphatic and blood vessels 
for earlier metastasis, late diagnosis of OSCC compared 
to CSCC due to less visibility, lack of safe margins and 
less capability to respect the entire tumor in oral cavity 
compared to skin due to more vicinity of oral cavity to 
vital organ and less accessibility in mouth and finally 
related to other molecules, markers and cells. Because 
of the novelty of current study in such a field 
(comparison of mean percentage of myofibroblasts and 
percentage classification of myofibroblasts between 
OSCC and CSCC) and lack of previous similar studies, 
it is not possible to compare this study with other 
studies from this standpoint. 
 
Conclusion 
 Although presence of stromal myofibroblasts probably 
help the progression and invasion of OSCC and CSCC, 
it cannot have much importance in different biological 
behavior of OSCC and CSCC. 
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